Our Team

Jim Menoutis

Chief Science Officer | 40+ Years of Analytical & Scientific Leadership

Dr. James “Jim” Menoutis is Chief Science Officer at Quantum Analytics Group, where he directs scientific operations at the company’s FDA-registered, ISO/IEC 17025-accredited laboratory in Monmouth Junction, NJ. With more than 40 years of experience, he leads programs in method development and validation, nitrosamine and NDSRI quantification, extractables and leachables, elemental impurities, residual solvents (including trace 1,4-dioxane and benzene), and unknown impurity identification for clients in the pharmaceutical, medical device, personal care, and specialty chemical industries.

His career includes scientific and leadership positions at SGS, Frutarom (formerly Meer), Enbionics, Quest Diagnostics (formerly MePath), Hoffmann-La Roche, Givaudan, and Quantex Laboratories. He is an internationally recognized authority on triclosan and its impurities, and his research has achieved international regulatory reach, entering the U.S. FDA regulatory record and being specifically cited in assessments by the Australian Government and the Cosmetic Ingredient Review (CIR).

He holds a Ph.D. in Analytical Chemistry, dual bachelor’s degrees in Chemistry (biochemistry concentration) and Mathematics, and a certificate in Toxicology. He is a Fellow of the American Institute of Chemists and holds certification as both a Certified Professional Chemist and a Certified Professional Chemical Engineer from the National Certification Commission in Chemistry and Chemical Engineering.

Angela Parisi Menoutis

Senior Scientist, Quality & Laboratory Operations | 40+ Years of Analytical & Scientific Leadership

Angela Parisi Menoutis is an analytical scientist and scientific manager with more than four decades of experience in analytical chemistry, method development, regulated quality testing, and laboratory operations. Her career spans pharmaceuticals, biotechnology, personal care and consumer products, and specialty chemicals.

Angela holds B.S. degrees in Chemistry and Biology and completed extensive graduate coursework toward an M.S. degree in Chemistry.  Her advanced technical training includes studying under Dr. Robert L. Grob in gas chromatography and Dr. Fred McLafferty and Dr. J. Throck Watson in mass spectrometry. Independently, she completed specialized training at the Finnigan Institute, developing advanced skills in GC-MS and tandem mass spectrometry (MS/MS).

Throughout her career, Angela has held scientific and management positions with Colgate-Palmolive, Lonza, Celgene, and Bristol Myers Squibb. Her experience includes chromatography and mass spectrometry, analytical method development, dissolution testing, trace-level analysis, pharmaceutical development, cGMP laboratory operations, and quality systems.

At Quantum Analytics Group, Angela combines her scientific expertise with decades of laboratory and quality experience to help ensure analytical work is scientifically sound, appropriately documented, and supported by rigorous quality systems. She also plays an important role in mentoring scientists and strengthening laboratory operations.

Angela has authored and co-authored scientific work involving elemental impurities, genotoxic impurities, and trace-level contaminants. Beyond the laboratory, she is also the author of two works of historical fiction.

Dimitri Kitsos

Co-Founder & Manager of Regulatory Services | 30+ Years of Scientific & Regulatory Experience

Dimitri Kitsos is an organic chemist and scientific and regulatory leader with more than three decades of experience spanning pharmaceutical development, specialty chemicals, R&D, Quality Assurance, and GMP-regulated analytical laboratories in the U.S. and Europe. He holds a B.S. in Chemistry and a Ph.D. in Organic Chemistry.

Throughout his career, Dimitri has held leadership positions including Principal Scientist, Group Leader, and Group Manager. His technical expertise includes advanced LC/MS, pharmaceutical development, impurity profiling, analytical problem solving, and regulatory support—from exploratory compound development through regulatory submissions.

As Co-Founder and Manager of Regulatory Services at Quantum Analytics Group, Dimitri combines scientific depth with regulatory insight to help clients develop analytically sound programs aligned with FDA and international regulatory expectations. His experience helps bridge the critical gap between good analytical science and regulatory compliance, supporting data and methods that are scientifically defensible and audit-ready.

Mary Oppel

Manager of Business Development | Client Engagement & Strategic Relationships

Mary Oppel serves as Manager of Business Development at Quantum Analytics Group, where she leads client engagement, relationship development, and new business opportunities. Her background in communications, combined with hands-on technical experience, enables her to understand client needs and connect them with Quantum's scientific capabilities.

Mary holds a B.S. in Communication and Journalism and expanded her technical knowledge through independent study and practical development in bioengineering, sensor design, and device integration. Her work in this area led to her becoming a named inventor on patents covering advanced biosensor systems, giving her a distinctive ability to understand and communicate complex technical concepts.

At Quantum, Mary works with clients and prospective partners to understand their analytical needs, build strategic relationships, and identify where Quantum's scientific expertise can provide value. Her combination of communication expertise, technical understanding, and relationship-building skills helps create the clear, collaborative client relationships that are central to Quantum's approach.

Jonathan Menoutis

Manager, Client Services & Project Management | Analytical Program Execution

Jonathan Menoutis brings 14 years of experience in the contract analytical laboratory industry, combining hands-on laboratory knowledge, business expertise, and project management experience across pharmaceuticals, medical devices, and personal care products.

Jonathan began his career as a laboratory technician, gaining practical analytical experience while earning an Associate's Degree in Science with a concentration in Chemistry. Building on this technical foundation, he advanced into project management roles supporting drug discovery, development, quality, and analytical testing programs. He subsequently earned a B.S. in Business Administration and a Graduate Certificate in Project Management, further strengthening his ability to coordinate complex, multidisciplinary projects. He is currently completing his MBA and preparing for the Project Management Professional (PMP®) examination.

At Quantum Analytics Group, Jonathan oversees client services, project coordination, and operational execution, translating client requirements into well-defined and efficiently managed analytical programs. His combination of laboratory experience, business knowledge, and project management training enables him to coordinate technical activities, timelines, communication, and deliverables from project initiation through completion.

Douglas Devaney

Manager of Information Technology | Laboratory Systems, Data Integrity & Cybersecurity

Douglas Devaney brings more than 11 years of IT leadership experience across regulated laboratory and enterprise environments. A U.S. Air Force veteran and graduate of a leading IT technical institute, he combines technical expertise with direct experience supporting cGMP laboratory operations.

Before joining Quantum Analytics Group, Doug worked with a major analytical testing laboratory serving the pharmaceutical, medical device, and personal care industries, where he gained hands-on experience managing IT systems in a cGMP environment. He later advanced into enterprise IT leadership, expanding his expertise in IT infrastructure, cybersecurity, and secure enterprise systems.

At Quantum, Doug leads the design, validation, security, and governance of laboratory technology systems. His expertise includes 21 CFR Part 11 compliance, ALCOA+ data integrity principles, laboratory informatics, chromatography data systems, LIMS, cybersecurity, and disaster recovery.

By integrating technology, data integrity, cybersecurity, and regulatory requirements, Doug helps ensure that Quantum's laboratory systems—and the analytical data they support—remain secure, traceable, reliable, and defensible.